Veterinary Packaging Shijiazhuang Xinfuda Medical Packaging Co., Ltd.

E-MAIL: [email protected]

FDA-DMF Query
Home > News

CDE issued a document to speed up the process of drug R&D and marketing

Mar 16 , 2021

On March 8, the Center for Drug Evaluation (CDE) of the National Medical Products Administration issued the "Technical Requirements for Pharmaceutical Research and Evaluation of Overseas Listed and Domestic Unlisted Chemical Drugs (Trial)". This document aims to further guide companies in drug research and development. Speed up the development and marketing process of overseas listed domestic unlisted chemical drugs, and provide reference technical standards.

CDE issued a document to speed up the process of drug R

child proof bottle

On February 26, 2016, the China Food and Drug Administration (CFDA) issued the "Opinions on Resolving the Backlog of Drug Registration Applications and Implementing Priority Review and Approval", which formally determined the scope of three types of priority review and approval drugs: innovative drugs, Children's medicines, urgently needed medicines, patent expired medicines and first generic medicines have received key support;

On January 30, 2018, the CFDA and the Ministry of Science and Technology issued the "Guiding Opinions on Strengthening and Promoting Food and Drug Technology Innovation". In terms of promoting pharmaceutical innovation, it proposed to build national laboratories around the drug and medical device innovation chain, and coordinate the promotion of national clinical trials. Various measures such as the construction of medical research centers;

On November 19, 2020, CDE issued the "Technical Guidelines for Conditional Approval of Drugs (Trial)" to encourage clinical value-oriented drug innovation and accelerate the marketing of clinically urgently needed drugs with outstanding clinical value...

With the continuous introduction of policies to encourage drug R&D and innovation, China's drug R&D has ushered in a golden age of development. While pharmaceuticals continue to innovate, they will also drive innovations in the pharmaceutical packaging industry. In particular, functional packaging that prevents children from opening bottles will receive more and more attention.

The function of preventing children from opening the bottle is mainly reflected in the bottle cap, which can be opened by pressing down and rotating at the same time. This opening method can effectively reduce children's random opening of the package and avoid accidental ingestion of medicines. With the support of various national policies, various new drugs will put forward more requirements on packaging, and the prevention of children from opening the bottle will also usher in benefits.


Back to List
Share:
HOT PRODUCTS

Copyright © Shijiazhuang Xinfuda Medical Packaging Co., Ltd. All Rights

Reserved Powered by    

MAKE AN ENQUIRY

verification

wechat